홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
ACRS
#2978
Aclaris Therapeutics, Inc.
3.9
2
USD
+0.51%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+0.51%
월간 변동
+8.59%
6달 변화
+111.89%
년간 변동율
+232.20%
이전 종가
3.9
0
Open
3.9
2
Bid
Ask
Low
3.9
2
High
3.9
2
양
41
마켓
주식
헬스케어
ACRS
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
51.8 M
61.28 M
66.69 M
70.93 M
107.92 M
120.6 M
—
Valuation ratios
Enterprise value
327.26 M
877.14 M
959.79 M
34.59 M
243.07 M
343.03 M
787.37 M
Price to earnings ratio
—
-9.09
-11.33
-0.83
-1.45
-5.68
-8.75
Price to sales ratio
—
122
33.03
2.35
10.24
47.14
71.67
Price to cash flow ratio
—
-15.82
-14.55
-0.94
-9.55
-7.83
295.07
Price to book ratio
—
4.18
4.97
0.47
1.23
3.58
4.4
EBITDA 비율에 대한 기업 가치
-17.26
-43.24
728.21
-2.55
-29.76
-21.73
-87.29
Profitability ratios
Return on assets %
-0.72
-0.36
-0.34
-0.45
-0.6
-0.4
-0.36
Return on equity %
-1.35
-0.46
-0.44
-0.56
-0.85
-0.63
-0.54
Return on invested capital %
-1 118.27
-1 086.25
-958.37
-798.73
-657.83
-351.69
-346.2
Gross margin %
20.81
30.29
86.48
89.05
85.09
73.28
278.85
Operating margin %
-785.44
-1 327.07
-302.01
-311.55
-758.18
-975.91
-4 554.14
EBITDA margin %
-279.93
-295.39
4.43
-43.39
-43.63
-201.67
-997.97
Net margin %
-787.03
-1 343.96
-292.11
-283.15
-705.48
-829.58
-3 876.59
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
3.87
8.94
10.55
4.16
3.99
3.36
16.23
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.08
0.04
0.12
0.14
0.09
0.04
0.04
Solvency ratios
Debt to assets ratio
0.2
0.05
—
—
—
—
—
Debt to equity ratio
0.38
0.07
—
—
—
—
—
Long term debt to total assets ratio
0.15
0.04
—
—
—
—
—
Long term debt to total equity ratio
0.28
0.05
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
-0.92
-1.04
-1.12
-0.26
-0.38
-0.38
EBIT per share
—
-1.58
-1.38
-1.39
-1.84
-0.62
-0.62
EBITDA per share
—
-0.35
0.02
-0.19
-0.11
-0.13
-0.13
Total debt per share
—
0.24
—
—
—
—
—
Cash per share
—
3.98
3.52
2.61
2.64
1.24
5.63
Net current asset value per share
—
3.61
3.55
1.85
1.63
0.79
3.35
Tangible book value per share
—
3.35
2.92
2.25
2.01
0.84
4.07
Working capital per share
—
3.21
3.21
1.4
1.22
0.55
2.51
Book value per share
—
3.48
3.03
2.25
2.01
0.84
4.07
뉴스
Profound Medical (PROF) Surges 13.0%: Is This an Indication of Further Gains?
아클라리스 테라퓨틱스, H.C. Wainwright ’매수’ 등급 재확인
Aclaris Therapeutics stock rating reiterated at Buy by H.C. Wainwright
스티펠, Aclaris Therapeutics 목표 주가 3달러로 상향
Stifel raises Aclaris Therapeutics stock price target to $3 on pipeline
Aclaris Therapeutics (ACRS) Reports Q4 Loss, Lags Revenue Estimates
Aclaris Therapeutics Inc Q4 실적, 수익 에상치보다 저조
Aclaris Therapeutics Inc earnings missed by $0.01, revenue fell short of estimates
Ionis Pharmaceuticals (IONS) Reports Q4 Loss, Tops Revenue Estimates
Corcept Therapeutics (CORT) Q4 Earnings and Revenues Miss Estimates
Aclaris, 천식 환자 대상 ATI-052 1b상 임상시험 개시
Aclaris starts phase 1b trial of ATI-052 in asthma patients